ConvaTec Group (LON:CTEC)‘s stock had its “hold” rating reissued by research analysts at Peel Hunt in a research report issued on Thursday. They currently have a GBX 250 ($3.45) price target on the stock. Peel Hunt’s price target points to a potential upside of 21.42% from the company’s current price.
CTEC has been the subject of several other reports. Deutsche Bank reaffirmed a “sell” rating and set a GBX 180 ($2.49) price objective on shares of ConvaTec Group in a research note on Friday, December 1st. Numis Securities raised shares of ConvaTec Group to a “reduce” rating and set a GBX 180 ($2.49) price objective for the company in a research note on Wednesday, October 18th. One analyst has rated the stock with a sell rating, seven have issued a hold rating and two have assigned a buy rating to the company. ConvaTec Group presently has an average rating of “Hold” and a consensus price target of GBX 245.78 ($3.40).
Shares of ConvaTec Group (LON CTEC) opened at GBX 209.70 ($2.90) on Thursday. The firm has a market cap of $3,770.00 and a PE ratio of -1,906.36. ConvaTec Group has a twelve month low of GBX 181.40 ($2.51) and a twelve month high of GBX 349.10 ($4.82).
ConvaTec Group Company Profile
ConvaTec Group Plc is a medical product and technology company. The Company focuses on therapies for the management of chronic conditions, including products used for advanced chronic and acute wound care, ostomy care, continence and critical care and infusion devices used in the treatment of diabetes and other conditions.
Receive News & Ratings for ConvaTec Group Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for ConvaTec Group and related companies with MarketBeat.com's FREE daily email newsletter.